Investor Presentaiton

Pharma Segment Performance Segment Revenue (RMB million) 12,248 16.97% YoY 14,327 1H21 1H22 Innovative Medicines Segment Results Segment Profit¹ (RMB million) (RMB million) 1,353 39.69% YoY 1,890 1,257 25.14% YoY 1,573 1H21 1H22 1H21 1H22 Pharma 3 Divisions Specialization Established Medicines Manufacturing & Supply Vaccine Note1: Segment profit excludes fair value changes of BNTX shares and gain on sale of certain shares 16

View entire presentation